Biogen Idec (BIIB), AbbVie (ABBV) Report Statistically Significant Data from Phase 3 DECIDE
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) and AbbVie (NYSE: ABBV) announced the full results from the Phase 3 DECIDE clinical trial, which ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
